SOBRE SOM BIOTECH (SOM)
SOM Biotech (SOM) is a clinical-stage biopharmaceutical company established at the Barcelona Science Park with the mission to discover and develop new indications of already known drugs (repositioning) through a profitable private company committed to its shareholders, employees and society. Repositioned drug access implies discovering, pre-clinical validation, patenting and licensing already known drugs for their commercial use in unknown medical uses. Our proprietary virtual screening platform is based on an in silico computerized approach and the drug development is driven by a dedicated team of experts and strategy advisors. SOM Biotech has a relevant interest in rare diseases.